Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

Carregando...
Imagem de Miniatura
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
TRZESNIAK, Clarissa
KEMPTON, Matthew J.
OLIVEIRA, Irismar Reis de
ALMEIDA, Amanda Galvao-de
KAMBEITZ, Joseph
FERRARI, Maria Cecilia Freitas
SANTOS FILHO, Alaor
CHAGAS, Marcos H. N.
ZUARDI, Antonio W.
Citação
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.35, n.4, p.877-886, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Magnetic resonance imaging (MRI) studies have reported a variety of brain abnormalities in association with schizophrenia. These include a higher prevalence of an absent adhesio interthalamica (Al; also known massa intermedia), a gray matter junction that is present between the two thalami in approximately 80% of healthy subjects. In this meta-analytic review, we describe and discuss the main Al MRI findings in schizophrenia spectrum disorders (SSDs) to date. The MEDLINE and ISI Web of Knowledge(SM) databases were searched up to December 2010, for studies that used MRI to assess Al in patients with SSD and controls. From fourteen potential reports, eleven were eligible to be part of the current review. These studies included 822 patients with SSD and 718 healthy volunteers. There was a large degree of variability in the MRI methods they employed. Patients with SSD had a higher prevalence of absent Al than healthy volunteers (odds ratio = 1.98; 95% confidence interval 1.33-2.94: p=0.0008). This association was evident in both male and female SSD subjects, and there was no evidence that the prevalence was related to age or duration of illness. The significance of the absence of an Al for SSD may be clarified by studies in large, longitudinal community-based samples using standardized methods.
Palavras-chave
Adhesio interthalamica, Magnetic resonance imaging, Massa intermedia, Meta-analysis, Schizophrenia, Thalamus
Referências
  1. Agarwal N, 2008, J PSYCHIATR NEUROSCI, V33, P440
  2. ALLEN LS, 1991, J COMP NEUROL, V312, P97, DOI 10.1002/cne.903120108
  3. American Psychiatric Association, 1987, DIAGN STAT MAN MENT
  4. American Psychiatric Association, 2000, DIAGN STAT MAN MENT
  5. American Psychiatric Association, 1994, DIAGN STAT MAN MENT
  6. Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3
  7. ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669
  8. SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773
  9. Kempton MJ, 2010, SCHIZOPHR RES, V120, P54, DOI 10.1016/j.schres.2010.03.036
  10. HIRAYASU Y, 1992, BRAIN RES, V577, P36, DOI 10.1016/0006-8993(92)90534-G
  11. Hill C, 1996, AM J PSYCHIAT, V153, P533
  12. Crippa JAD, 2006, EUR PSYCHIAT, V21, P291, DOI 10.1016/j.eurpsy.2005.09.010
  13. Susser E, 1998, BIOL PSYCHIAT, V44, P141, DOI 10.1016/S0006-3223(97)00427-7
  14. Takahashi T, 2008, PROG NEURO-PSYCHOPH, V32, P1708, DOI 10.1016/j.pnpbp.2008.07.007
  15. Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
  16. Chakos MH, 2005, BRIT J PSYCHIAT, V186, P26, DOI 10.1192/bjp.186.1.26
  17. Takahashi T, 2008, PSYCHIAT RES-NEUROIM, V162, P101, DOI 10.1016/j.pscychresns.2007.04.005
  18. Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
  19. Jakobsen KD, 2006, PSYCHOPATHOLOGY, V39, P269, DOI 10.1159/000095731
  20. Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
  21. WRIGHT P, 1995, AM J PSYCHIAT, V152, P1714
  22. Takahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P1058, DOI 10.1016/j.pnpbp.2009.05.020
  23. Tomelleri L, 2009, EUR NEUROPSYCHOPHARM, V19, P835, DOI 10.1016/j.euroneuro.2009.07.007
  24. Naylor CD, 1997, BRIT MED J, V315, P617
  25. Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034
  26. Takahashi T, 2010, J AFFECT DISORDERS, V122, P301, DOI 10.1016/j.jad.2009.09.003
  27. ROSALES RK, 1968, J NEUROPATH EXP NEUR, V27, P166
  28. Takahashi T, 2008, PSYCHIAT RES-NEUROIM, V164, P90, DOI 10.1016/j.pscychresns.2008.03.001
  29. Egger M, 1997, BRIT MED J, V315, P629
  30. Kwon JS, 1998, AM J PSYCHIAT, V155, P509
  31. Shimizu M, 2008, SCHIZOPHR RES, V101, P331, DOI 10.1016/j.schres.2007.12.486
  32. Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562
  33. Trzesniak C, 2011, SCHIZOPHR RES, V125, P1, DOI 10.1016/j.schres.2010.09.016
  34. Cohen BM, 1998, PSYCHOPHARMACOLOGY, V135, P37, DOI 10.1007/s002130050483
  35. SAMRA KA, 1968, RADIOLOGY, V91, P1124
  36. MCGLONE J, 1980, BEHAV BRAIN SCI, V3, P215
  37. WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202
  38. Kasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010
  39. Ceyhan M, 2008, ACTA NEUROPSYCHIATR, V20, P193, DOI 10.1111/j.1601-5215.2008.00296.x
  40. Cheniaux E, 2009, PSYCHOPATHOLOGY, V42, P293, DOI 10.1159/000228838
  41. CHERAMY A, 1984, NEUROSCI LETT, V44, P193, DOI 10.1016/0304-3940(84)90080-6
  42. Cohen BM, 1996, AM J PSYCHIAT, V153, P104
  43. Erbagci H, 2002, SCHIZOPHR RES, V55, P89, DOI 10.1016/S0920-9964(01)00199-2
  44. Ettinger U, 2007, ARCH GEN PSYCHIAT, V64, P401, DOI 10.1001/archpsyc.64.4.401
  45. Hallak JEC, 2007, ARQ NEURO-PSIQUIAT, V65, P1216, DOI 10.1590/S0004-282X2007000700024
  46. Jager M, 2004, PSYCHOPATHOLOGY, V37, P110, DOI 10.1159/000078609
  47. Kuloglu M, 2008, PROG NEURO-PSYCHOPH, V32, P1353, DOI 10.1016/j.pnpbp.2008.04.014
  48. LEVIEL V, 1981, BRAIN RES, V223, P257, DOI 10.1016/0006-8993(81)91140-9
  49. Malobabić S, 1987, Gegenbaurs Morphol Jahrb, V133, P175
  50. Meisenzahl EM, 2002, PSYCHIAT RES-NEUROIM, V115, P127, DOI 10.1016/S0925-4927(02)00044-6
  51. Meisenzahl EM, 2000, AM J PSYCHIAT, V157, P823, DOI 10.1176/appi.ajp.157.5.823
  52. MURRAY RM, 1987, BRIT MED J, V295, P681
  53. Nopoulos PC, 2001, SCHIZOPHR RES, V48, P177, DOI 10.1016/S0920-9964(00)00067-0
  54. ROMO R, 1984, BRAIN RES, V308, P43, DOI 10.1016/0006-8993(84)90915-6
  55. Sharp S, 1998, STATA TECH B, V42, P16, DOI 10.1002/SIM.1187/FULL)
  56. Snyder PJ, 1998, J NEUROIMAGING, V8, P159
  57. STONE JM, 2010, PSYCHIAT RES, V30, P174
  58. STONE JM, 2009, BIOL PSYCHIAT, V15, P533
  59. Sutton A.J., 2000, METHODS METAANALYSIS
  60. Takahashi T, 2008, PROG NEURO-PSYCHOPH, V32, P1236, DOI 10.1016/j.pnpbp.2008.03.014
  61. Takahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P842, DOI 10.1016/j.pnpbp.2009.03.035
  62. Toda Mitsuru, 2007, Curr Psychiatry Rep, V9, P329, DOI 10.1007/s11920-007-0041-7
  63. WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660
  64. Wilson Christina, 2010, Clin Schizophr Relat Psychoses, V4, P124, DOI 10.3371/CSRP.4.2.4